Strata Critical Medical, Inc.
Company Information
Industry Services-Health Services
SIC Code 8000
Entity Type operating
SEC Category Accelerated filerSmaller reporting company
State of Incorporation DE
Business Address 31 HUDSON YARDS, NEW YORK, NY, 10001
Mailing Address 31 HUDSON YARDS, NEW YORK, NY, 10001
Phone 212-967-1009
Fiscal Year End 1231
EIN 841890381
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 4/A Insider transaction amendment | March 23, 2026 | View on SEC |
| 4 Insider stock transaction report | March 18, 2026 | View on SEC |
| 4 Insider stock transaction report | March 10, 2026 | View on SEC |
| 4 Insider stock transaction report | March 10, 2026 | View on SEC |
| 4 Insider stock transaction report | March 10, 2026 | View on SEC |
| 4 Insider stock transaction report | March 10, 2026 | View on SEC |
| 8-K Current report of material events | March 3, 2026 | View on SEC |
| 10-K Annual financial report | March 3, 2026 | View on SEC |
| 4 Insider stock transaction report | February 26, 2026 | View on SEC |
| 4 Insider stock transaction report | February 26, 2026 | View on SEC |
Annual Reports
10-K March 3, 2026
- Strata strategically acquired Keystone Perfusion Services LLC in September 2025 for $35 million, significantly expanding its critical clinical services.
- The company secured a new $20 million asset-backed revolving credit facility in January 2026, enhancing financial flexibility for future growth and liquidity.
Insider Trading
BUY 3 insiders
4 recent transactions
View Full Insider Trading Profile
Related Companies
Companies in the same industry (SIC: 8000)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.